Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000287419

Medchemexpress LLC 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)p... | 2845104-25-6 | 99.7% | 443.50 g·mol⁻¹ | C27H21N7 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY15162210MG

Encompass_Preferred

An orally active small-molecule dual inhibitor of PI3K and mTOR developed for preclinical cancer research. Supplied as a high-purity solid with recommended solubility and storage conditions for both in vitro and in vivo experiments.

  • Dual PI3K and mTOR inhibition with low-nanomolar potency (PI3Kα 3.5 nM; PI3Kδ 4.6 nM; mTOR 21.3 nM)
  • High purity suitable for research applications (99.65%)
  • Solid, off-white to gray appearance and stable under recommended storage
  • Soluble in DMSO (40 mg/mL) and formulatable for in vivo dosing (10% DMSO/corn oil)
  • Multiple packaging formats for in vitro and in vivo use
  • Includes storage guidance for solutions (-80°C/-20°C) and solids (4°C protected from light)

Catalog No. 50-002-87419


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.